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Introduction
Copper is a trace element that is critical for aerobic life. Its ability
to accept and donate electrons has been harnessed by a select group
of enzymes that function in mitochondrial respiration, connective
tissue formation, pigmentation, iron oxidation, neurotransmitter
processing and antioxidant defense (La Fontaine and Mercer, 2007;
Madsen and Gitlin, 2007; Prohaska and Gybina, 2004). However,
this same redox property of copper and its ability to generate reactive
oxygen species, also underscores its potential toxicity. For this
reason, copper-handling proteins have evolved to deliver copper to
specific sites of utilization, thereby preventing the formation of
potentially damaging free ionic copper in the cytoplasm. Copper
uptake in mammalian cells is mediated by CTR1 (SLC31A1), a
ubiquitously expressed homotrimeric transporter (Zhou and
Gitschier, 1997). Once in the cytoplasm, small cytoplasmic proteins
known as copper chaperones deliver copper to distinct target
enzymes by direct protein-protein interactions. The copper
chaperones, CCS and COX17 are involved in copper delivery to
Cu/Zn superoxide dismutase (SOD1) in the cytoplasm, and to
cytochrome c oxidase (CCO) in the mitochondria (Amaravadi et
al., 1997; Casareno et al., 1998). SCO1 and SCO2 are copper
chaperones that are also involved in copper delivery to CCO via a
poorly understood process (Leary et al., 2004). The third target for
copper delivery is the ATP7A protein (or closely related ATP7B
protein), a copper transporter located in the Golgi complex that
receives copper from the ATOX1 copper chaperone in the cytoplasm
(Larin et al., 1999; Petris et al., 1996; Yamaguchi et al., 1996).
ATP7A transports copper into the Golgi lumen to supply copper to
a select group of copper-dependent enzymes, which are either
secreted from cells, or reside within vesicular compartments (Barnes
et al., 2005; El Meskini et al., 2003; Petris et al., 2000; Qin et al.,
2006). An additional function of ATP7A is the export of excess
copper from cells. This export activity is associated with copper-
stimulated trafficking of ATP7A to post-Golgi compartments,
including cytoplasmic vesicles and the plasma membrane (Petris
et al., 1996). The trafficking of ATP7A is triggered when
cytoplasmic copper levels are elevated (Hamza et al., 2003), and
this process requires both copper binding to cytoplasmic regions
of the ATPase as well as its catalytic turnover (Petris et al., 2002;
Strausak et al., 1999). The biological importance of the ATP7A
protein is illustrated by Menkes disease, a lethal disorder of copper
deficiency caused by ATP7A mutations (Kaler, 1998).
An area of copper metabolism of which we have little
understanding is whether specific pathophysiological conditions
lead to adaptive changes in intracellular copper homeostasis.
Hypoxia is a stress that is inherent within the microenvironment of
injured tissues, including dermal wounds and burns (Arnold, 1987),
atherosclerotic plaques (Moreno et al., 2006) and avascular regions
of solid tumors (Bristow and Hill, 2008). Cells of the myeloid
lineage such a macrophages are specifically recruited to these
hypoxic sites and are metabolically adapted to function within this
hostile milieu. For example, it has been known for many years that
neutrophils and macrophages are highly dependent on anaerobic
glycolysis for ATP production, and suppress oxidative
phosphorylation in the presence of hypoxia (Simon et al., 1977).
In this study we investigated the impact of hypoxia on copper
Copper is an essential nutrient for a variety of biochemical
processes; however, the redox properties of copper also make
it potentially toxic in the free form. Consequently, the uptake
and intracellular distribution of this metal is strictly regulated.
This raises the issue of whether specific pathophysiological
conditions can promote adaptive changes in intracellular copper
distribution. In this study, we demonstrate that oxygen
limitation promotes a series of striking alterations in copper
homeostasis in RAW264.7 macrophage cells. Hypoxia was
found to stimulate copper uptake and to increase the expression
of the copper importer, CTR1. This resulted in increased
copper delivery to the ATP7A copper transporter and copper-
dependent trafficking of ATP7A to cytoplasmic vesicles.
Significantly, the ATP7A protein was required to deliver copper
into the secretory pathway to ceruloplasmin, a secreted copper-
dependent enzyme, the expression and activity of which were
stimulated by hypoxia. However, the activities of the alternative
targets of intracellular copper delivery, superoxide dismutase
and cytochrome c oxidase, were markedly reduced in response
to hypoxia. Collectively, these findings demonstrate that copper
delivery into the biosynthetic secretory pathway is regulated by
oxygen availability in macrophages by a selective increase in
copper transport involving ATP7A.
Key words: ATP7A, Copper, Hypoxia, Macrophage, Oxygen,
Trafficking
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homeostasis in the murine macrophage cell line, RAW264.7.
Hypoxia resulted in increased copper uptake and enhanced the
expression of the CTR1 transporter. Copper delivery to the ATP7A
protein was also enhanced as evidenced by trafficking from the
Golgi and enhanced copper transport into the secretory pathway to
ceruloplasmin. By contrast, hypoxia triggered a decrease in the
levels of other intracellular copper targets including, CCS, SOD1,
and the copper-binding subunit of CCO, COX1. These findings
suggest that oxygen status can regulate copper allocation to the
secretory pathway for hypoxia-induced cuproenzymes, and reveal
hypoxia as a unique pathophysiological regulator of intracellular
copper hierarchy.
Results
Hypoxia stimulates trafficking of the ATP7A protein in
RAW264.7 macrophages
We began this study by investigating whether reduced oxygen
tension might alter the localization of the ATP7A copper transporter
in the murine macrophage cell line, RAW264.7. The relocalization
of ATP7A from the trans-Golgi network is a key biological indicator
of increased cytoplasmic copper availability and has been
documented in several different cell types (Cobbold et al., 2002;
La Fontaine et al., 1998; Petris et al., 1996). Using
immunofluorescence microscopy, the ATP7A protein was found
within the perinuclear region of RAW264.7 cells exposed to
normoxic conditions (21% O2), consistent with its location in the
trans-Golgi network (Fig. 1A). As expected, treatment of these cells
with copper resulted in the trafficking of ATP7A from the
perinuclear region to cytoplasmic vesicles (Fig. 1A). Significantly,
when these cells were exposed to chronic hypoxia (4% O2 for 96
hours), the ATP7A protein was also dispersed to post-Golgi vesicles
(Fig. 1A). This redistribution of the ATP7A protein required at least
48 hours of hypoxia and was not accelerated by lower levels of
oxygen (data not shown). The return of hypoxic cells to normoxic
conditions restored the location of the ATP7A protein to the
perinuclear region, indicating that the effect of hypoxia on ATP7A
was reversible (Fig. 1A). The intracellular location of the trans-
Golgi marker protein, syntaxin 6 (STX6) and the Golgi matrix
protein, GM130, were not altered by hypoxia in RAW264.7 cells
(Fig. 1B,C), suggesting that the effects on ATP7A were not the result
of a general effect on Golgi structure. The viability of RAW264.7
cells was not altered by these conditions and cells could be
passaged continuously in 4% O2 (data not shown).
Oxygen limitation stimulates ATP7A expression and copper-
dependent trafficking of ATP7A
Since the trafficking of ATP7A from the trans-Golgi network is
known to be triggered by increased copper delivery to this
transporter (Petris et al., 1996), we tested whether a membrane-
permeable copper chelator, tetrathiomolybdate (TTM), could
suppress ATP7A trafficking in response to hypoxia in RAW264.7
cells. As shown in Fig. 2A, TTM inhibited ATP7A relocalization
in response to hypoxia. These findings support the hypothesis that
oxygen limitation increases copper binding to the ATP7A protein,
resulting in its trafficking from the Golgi. We also explored the
possibility that hypoxia may also increase the expression of ATP7A
in RAW264.7 macrophages. Western blot analysis demonstrated that
hypoxia increased ATP7A protein levels above normoxic controls
in a time-dependent manner, beginning between 24 and 48 hours
(Fig. 2B). A similar increase in ATP7A levels was observed in
primary peritoneal macrophages isolated from C57BL mice and
cultured under hypoxic conditions (Fig. 2C). These findings suggest
that hypoxia stimulates copper-dependent trafficking and expression
of the ATP7A protein.
Hypoxia stimulates trafficking of the ATP7A protein in tumor-
associated macrophages
We then sought to confirm whether hypoxia could elicit similar
changes in ATP7A localization in hypoxic macrophages in vivo.
Previous studies have demonstrated that macrophages are recruited
to the hypoxic regions of solid tumors where they play important
roles in promoting angiogenesis (reviewed by Mantovani et al.,
2006). A prostate tumor xenograft model provided an opportunity
to investigate the intracellular distribution of ATP7A in these
hypoxic tumor-associated macrophages. The tumorigenic human
prostate cell line, PC-3, was chosen for these studies since ATP7A
expression was very low in these cells, thus allowing for easy
identification of ATP7A in macrophages recruited to the tumor. PC-
3 tumors were grown in immunocompromised SCID mice for 5
weeks to a size of approximately 1 cm diameter (0.5 g), and then
excised and cryosectioned for immunofluorescence analysis of
ATP7A expression. This revealed abundant ATP7A protein
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Fig. 1. Hypoxia stimulates trafficking of the ATP7A protein.
(A) Immunofluorescence analysis of ATP7A protein in RAW264.7 cells grown
under normoxic (21% O2) or hypoxic (4% O2) conditions for 96 hours. Cells
were fixed, permeabilized and probed with antibodies against for ATP7A and
anti-rabbit antibodies conjugated to Alexa Fluor 488 (green). Nuclei were
labeled with DAPI (blue). Note the trafficking of ATP7A protein from the
perinuclear region in hypoxic cells and copper-treated normoxic cells. ATP7A
was rapidly retrieved to the perinuclear compartment upon the transfer of
hypoxic cells to normoxic media for 30 minutes (HyprNorm). (B,C) Analysis
of Golgi marker proteins in hypoxic RAW264.7 cells. Cells were cultured
under hypoxic or normoxic conditions as described in A and probed using
antibodies against the trans-Golgi network marker protein syntaxin 6 (B), or
the Golgi matrix protein, GM130 (C). Nuclei were labeled with DAPI (blue).
Scale bars: 7 μm.
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expression in tumor-associated macrophages that were identified
using the macrophage-specific marker CD-68 (Fig. 3A). As
expected, there was little if any expression of ATP7A in the PC-3
tumor cells (Fig. 3A). Consistent with previous studies, the
macrophages were typically concentrated at the tumor edges, with
occasional infiltration into the tumor body (Biswas et al., 2006;
Lewis and Pollard, 2006; Murdoch et al., 2004). It was noted that
in some macrophages ATP7A was restricted to the perinuclear Golgi
complex, whereas in other macrophages ATP7A was dispersed
throughout the cell in a manner reminiscent of the trafficking seen
earlier in cultured hypoxic RAW264.7 cells (Fig. 3A, lower left
panel). Significantly, this dispersed localization of the ATP7A
protein occurred only in macrophages that coexpressed the HIF1α
protein (Fig. 3B). The HIF1α transcription factor is the master
regulator of gene expression responses to low oxygen, and is
upregulated in macrophages within hypoxic areas of tumors (Burke
et al., 2002; Talks et al., 2000). These findings, together with our
earlier observations in cultured RAW264.7 cells, suggest that
hypoxia triggers copper-dependent trafficking of ATP7A in
macrophages.
Oxygen limitation stimulates the expression of CTR1 and
copper uptake in macrophages
Based on our finding that the trafficking of ATP7A in response to
hypoxia was dependent on copper, we investigated whether this
might occur through increased copper uptake. Radioactive 64Cu
uptake experiments were carried out using RAW264.7 macrophages
that had been pre-exposed to hypoxic or normoxic conditions. A
significant increase in copper uptake was found for RAW264.7 cells
pre-exposed to hypoxia relative to normoxia (Fig. 4A). Interestingly,
this increased copper uptake was associated with a time-dependent
increase in the levels of the CTR1 copper importer (Fig. 4B). A
similar increase in CTR1 expression was observed in murine
primary peritoneal macrophages cultured under hypoxic conditions
(Fig. 4C). Taken together with our earlier results, these findings
suggest that the copper-dependent trafficking the ATP7A protein
is associated with an increase in CTR1 expression and copper
uptake.
Hypoxia stimulates copper transport to ceruloplasmin via
ATP7A
The major function of ATP7A is to pump copper into the secretory
pathway to supply copper to secreted cuproenzymes. We
hypothesized that a potential target for this copper delivery in
response to hypoxia might be ceruloplasmin, a cuproenzyme that
requires copper delivery into the secretory pathway. Ceruloplasmin
is a ferroxidase secreted from macrophages and hepatocytes, the
expression and activity of which are stimulated by hypoxia (Martin
et al., 2005; Mukhopadhyay et al., 2000). Hypoxia was found to
Fig. 2. Hypoxia stimulates both copper-dependent trafficking and increased
expression of ATP7A. (A) RAW264.7 cells were cultured under hypoxic or
normoxic conditions as described in Fig. 1 in the presence or absence of the
copper chelator, tetrathiomolybdate (TTM; 5 nM). ATP7A protein was
detected using immunofluorescence as described in Fig. 1. Scale bars: 10 μm.
(B,C) Immunoblot analysis of ATP7A protein in RAW264.7 cells (B) and
primary peritoneal macrophages (C) cultured under normoxic (N; 21% O2) or
hypoxic (H; 4% O2) conditions for the indicated times. Tubulin was detected
as a loading control. Relative ATP7A band intensities at each time point
normalized against tubulin are shown for each normoxic and hypoxic pair.
Fig. 3. ATP7A trafficking in HIF1α-positive tumor-associated macrophages.
(A) ATP7A is strongly expressed in tumor-associated macrophages. Human
prostate cell PC-3 xenograft tumors from SCID mice were cryosectioned and
probed with antibodies against ATP7A (green) or antibodies against the
macrophage marker CD68 (red). Nuclei were stained using DAPI (blue).
Upper panels show both the tumor mass and the tumor edge, with strong
ATP7A expression in CD68-positive macrophages associated with the tumor
edge Scale bar: 60 μm. The lower panels are higher magnifications of the
tumor periphery and reveal extensive coexpression of ATP7A in CD68-
positive macrophages, as indicated by yellow signal in the merged image.
Scale bar: 30 μm. The arrow and arrowhead (lower left panel) indicate
heterogeneous localization of the ATP7A in macrophages, in either a
perinuclear or dispersed distribution. (B) The dispersed distribution of the
ATP7A occurs in HIF1α-positive macrophages. Three different PC-3 tumor
cryosections were immunostained for ATP7A (green) and HIF1α staining
(red). ATP7A was restricted to the perinuclear region of macrophages negative
for HIF1α expression (arrows), whereas a dispersed distribution of ATP7A
occurred in HIF1α-positive macrophages (arrowheads) (original
magnification, 600). Scale bar: 10 μm.
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increase both the abundance and the activity of ceruloplasmin
secreted into the culture medium of RAW264.7 cells relative to
normoxia (Fig. 5A,B). To examine whether the increase in
ceruloplasmin activity was dependent on ATP7A copper transport
activity, we depleted ATP7A expression in RAW264.7 cells using
RNAi-mediated gene silencing (ATP7A/RNAi cells; Fig. 5C).
Control cells were transfected with a construct expressing an
irrelevant RNAi against GFP (Fig. 5C). Compared with control cells,
ceruloplasmin activity in ATP7A/RNAi cells was markedly reduced
under hypoxic conditions, suggesting that ATP7A copper transport
activity was required for copper delivery to ceruloplasmin (Fig. 5D).
Consistent with this postulate, the addition of copper to the medium
of these cells bypassed the requirement for ATP7A and restored
ceruloplasmin activity, indicating that the effect of ATP7A gene
silencing was due to a blockage of copper delivery to ceruloplasmin
(Fig. 5D). Control experiments indicated that ATP7A silencing did
not alter ceruloplasmin protein levels in the medium relative to
control cells in either hypoxic or normoxic conditions (data not
shown). Taken together with our earlier results, these findings
suggest that hypoxia stimulates an increase in copper delivery to
ceruloplasmin by increasing CTR1-mediated copper uptake as well
as ATP7A-dependent copper delivery into secretory compartments.
Hypoxia differentially affects intracellular copper pathways
Having established that hypoxia increases the delivery of copper
to ceruloplasmin via the ATP7A copper transporter, we explored
the effect of hypoxia on two additional targets of intracellular copper
pathways. These include Cu/Zn-superoxide dismutase (SOD1) in
the cytoplasm and CCO in the mitochondria. Hypoxia resulted in
a time-dependent decrease of SOD1 activity in RAW264.7
macrophages (Fig. 6A). Interestingly, this reduction in SOD1
activity was associated with a marked reduction in the level of CCS
protein, which is the copper chaperone required for copper delivery
to SOD1 (Fig. 6B). The activity of the cuproenzyme, CCO, was
also markedly reduced in mitochondrial preparations isolated from
hypoxic RAW264.7 macrophages (Fig. 6C), and this was
accompanied by reduced levels of COX1 protein, a copper
containing subunit of CCO (Fig. 6D). Hypoxia did not result in
detectable changes in other copper chaperones COX17, SCO1 or
SCO2, which are required for copper delivery to CCO (data not
shown). Taken together, these findings suggest that hypoxia
differentially impacts intracellular copper handling pathways by
decreasing copper delivery to SOD1 and CCO, while up-regulating
copper delivery to the secretory pathway via ATP7A.
Discussion
Hypoxia is a stress that is commonly encountered by macrophages
as they migrate away from the vasculature. Accordingly, this cell
type is uniquely adapted to function within this hostile
microenvironment. In this study we demonstrate that reduced
oxygen levels promote adaptive changes in intracellular copper
homeostasis in macrophages by specifically enhancing copper
delivery to the biosynthetic pathway via the ATP7A protein
(illustrated in Fig. 7). Copper-dependent trafficking of the ATP7A
protein from the trans-Golgi network is one of the clearest biological
indicators of increased cytoplasmic copper concentrations. Previous
studies have shown that copper-stimulated trafficking is dependent
Journal of Cell Science 122 (9)
Fig. 4. Hypoxia stimulates copper uptake and CTR1 expression in RAW264.7
macrophages. (A) Copper uptake activity. RAW264.7 cells were pre-exposed
to normoxia (21% O2) or hypoxia (4% O2) for 72 hours and 
64Cu uptake was
measured over 5 minutes. Values were normalized against total protein
concentrations (mean + s.d.; n=3; *P<0.05). (B,C) The effect of hypoxia on
CTR1 protein levels in RAW264.7 cells (B) and primary peritoneal
macrophages (C) cultured under normoxia (N; 21% O2) or hypoxia (H; 4%
O2) for the indicated times. Immunoblot analysis was used to detect CTR1
protein in lysates using anti-CTR1 antibodies. Tubulin was detected as a
loading control. Relative CTR1 band intensities at each time point, normalized
against tubulin, are shown for each normoxic and hypoxic pair.
Fig. 5. ATP7A-dependent copper transport is required for hypoxia-stimulated
ceruloplasmin activity. (A) Immunoblot analysis of ceruloplasmin (Cp)
secreted from RAW264.7 cells grown under normoxic (N; 21% O2) or hypoxic
(H; 4% O2) conditions for the indicated times. Conditioned medium was
concentrated and subjected to non-denaturing SDS-PAGE and immunoblot
analysis with anti-Cp antibodies. Tubulin levels from corresponding cell
lysates are also shown. Lane 1 is a negative control of concentrated growth
medium alone (M). (B) Hypoxia stimulates ceruloplasmin activity.
Ceruloplasmin activity (p-phenylenediamine oxidase activity) was measured
in the concentrated conditioned medium from RAW264.7 cells following
exposure to normoxia (N; 21% O2) or hypoxia (H; 4% O2) for 72 hours.
Activity was normalized against total protein content of the corresponding cell
lysates (mean + s.d.; n=3). (C) RNAi-mediated silencing of the ATP7A
protein. Immunoblot analysis of ATP7A protein levels in RAW264.7 cells
stably transfected with either ATP7A-RNAi or control-RNAi.
(D) Ceruloplasmin activity was measured in conditioned medium from the
ATP7A-RNAi or control-RNAi cells exposed to hypoxia (N; 21% O2) or
hypoxia (H; 4% O2) for 72 hours (mean + s.d.; n=3). Note the failure to
activate ceruloplasmin in ATP7A-depleted cells, and the restoration by
addition of copper to the growth medium (+Cu).
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on ATP7A copper transport activity as well as copper binding to
cysteines within its amino-terminal region (Strausak et al., 1999;
Petris et al., 2002). Our finding that hypoxia stimulated the
relocalization of ATP7A to post-Golgi vesicles in a copper-
dependent manner is consistent with increased copper binding to
this protein, as well as an increase in its copper transport activity
into the secretory pathway. This was supported by the finding that
the increased activity of ceruloplasmin, an enzyme that acquires
copper within secretory compartments, was dependent on ATP7A
expression in hypoxic cells.
In contrast to ceruloplasmin, the abundance and/or activity of
CCS, SOD1 and CCO were reduced by hypoxia. These findings
provide the first evidence that the pathways of intracellular copper
distribution can be differentially regulated in response to an
environmental stress. By reducing the flow of copper from CCS to
SOD1, this may provide a mechanism to redirect copper to the
ATP7A protein. Like SOD1, the activity of CCO was also
diminished by hypoxia in RAW264.7 cells and this was associated
with a decrease in levels of COX1 protein, the subunit of CCO
containing the CuB site. Although a decrease in CCO activity has
been previously reported in hypoxic macrophages to facilitate the
metabolic shift from oxidative phosphorylation to glycolysis
(Murphy et al., 1984; Simon et al., 1977), our findings highlight
the possibility that COX1 depletion serves an additional purpose
of diverting precious copper stores to secretory compartments via
ATP7A.
The finding that ceruloplasmin was a recipient of increased
copper delivery to the secretory pathway is in agreement with the
function of this protein in iron homeostasis. Ceruloplasmin is a
ferroxidase required for cellular iron export, which is a critical step
in the loading of iron onto transferrin in the blood (Nittis and Gitlin,
2002). This process is an adaptive response to hypoxia to meet the
increased iron demand of hematopoiesis (Sarkar et al., 2003). Thus,
the prioritization of copper delivery to ceruloplasmin via ATP7A
may ultimately function to regulate iron homeostasis in response
to hypoxia. The finding that ATP7A trafficking in hypoxic cells
occurred concurrently with ceruloplasmin activation raises the
possibility that under hypoxic conditions, copper delivery to
ceruloplasmin may occur in post-Golgi vesicles rather than in the
trans-Golgi network where copper loading normally takes place.
Thus, ATP7A trafficking may not simply reflect an increased flux
Fig. 6. Hypoxia downregulates alternative copper pathways in RAW264.7
macrophages. (A) Effect of hypoxia on SOD1 protein and activity. RAW264.7
cells were grown under normoxic (N; 21% O2) or hypoxic (H; 4% O2)
conditions for the indicated times. Cell lysates were subjected to non-
denaturing SDS-PAGE for the in-gel SOD1 activity assay (top panel).
Immunoblots from the same lysates were probed with anti-SOD1 antibodies to
detect SOD1 protein. Tubulin was detected as a loading control. Relative
SOD1 band intensities at each time point, normalized against tubulin, are
shown for each normoxic and hypoxic pair. (B) Effect of hypoxia on the
abundance of CCS, the copper chaperone for SOD1. The same lysates as in A
were subjected to SDS-PAGE and immunoblot analysis with anti-CCS
antibodies and relative band intensities at each time point normalized against
tubulin are shown for each normoxic and hypoxic pair. (C) Analysis of CCO
activity in hypoxic (shaded bars) and normoxic (solid bars) conditions.
Activity was measured in mitochondrial preparations isolated from RAW264.7
cells cultured as described in A. Values were normalized against total
mitochondrial protein (mean + s.d.; n=3; *P<0.05). (D) Analysis of COX1
protein levels in RAW264.7 cells cultured under normoxic (N; 21% O2) or
hypoxic (H; 4% O2) conditions for the indicated times. Mitochondrial
preparations from B were subjected to SDS-PAGE and probed with antibodies
against the copper-binding subunit COX1 of the CCO complex. Immunoblots
were probed with an antibody against porin to indicate protein loading, and
relative COX1 band intensities at each time point, normalized against porin,
are shown for each normoxic and hypoxic pair.
Fig. 7. Schematic model of hypoxia-induced changes in copper homeostasis
resulting in ATP7A-mediated copper transport to the secretory pathway.
Effects of hypoxia (H) include: (1) increased expression of the CTR1 copper
importer and increased copper uptake; (2) decreased CCS expression; (3)
reduced activity of SOD1; (4) reduced CCO activity and reduced expression of
COX1; (5) increased expression of ATP7A; (6) copper-dependent trafficking
of ATP7A; and (7) ATP7A-dependent copper transport to the secretory
pathway of ceruloplasmin.
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of copper to this protein, but facilitate copper-loading of
ceruloplasmin in post-Golgi compartments. Indeed, a recent study
demonstrating a subset of ATP7A protein was required in post-Golgi
melanosomes for the copper loading of tyrosinase is consistent with
this model (Setty et al., 2008). A particularly intriguing finding of
our study was the strong expression of ATP7A in tumor-associated
macrophages. Copper has been shown to play an important role in
angiogenesis, and copper chelation via TTM has proved to be an
effective suppressor of tumor growth in animals (Alessandri et al.,
1984; Camphausen et al., 2004; Cox et al., 2003; Cox et al., 2001;
Pan et al., 2003a; Pan et al., 2003b; Pan et al., 2002; Redman et
al., 2003; Teknos et al., 2005). It is therefore tempting to speculate
that the adaptive changes in macrophage copper homeostasis
described in this study may underlie the role of copper in tumor
growth.
A notable finding of our study was that the changes in copper
homeostasis in response to hypoxia appear to be restricted to
macrophages. ATP7A trafficking and/or changes in SOD1 and CCO
activity were not observed in our analysis of cultured cells from a
variety of sources including HeLa (cervical carcinoma), HEK293
(human embryonic kidney), N2a (neuroblastoma), primary human
aortic endothelial cells and primary rat smooth muscle cells (data
not shown). The macrophage-specific effects of hypoxia on copper
homeostasis may reflect inflammatory responses, since hypoxia is
known to specifically activate inflammatory pathways in
macrophages (Rius et al., 2008). Consistent with this postulate, our
unpublished studies demonstrate that pro-inflammatory agents can
stimulate copper-dependent ATP7A trafficking in macrophages
under normoxic conditions. It will be of interest to determine
whether other physiological conditions regulate changes in the
intracellular distribution of copper in other mammalian cell types.
For example, copper transport via ATP7A is required for melanin
production via tyrosinase, norepinephrine synthesis via dopamine
β-hydroxylase, and collagen cross-linking via lysyl oxidase, and
each of these cuproenzymes is stimulated by particular physiological
cues in specific cell types. The challenge of future studies will be
to address whether this involves adaptive changes that promote an
increase in ATP7A-dependent copper transport into the secretory
pathway.
Materials and Methods
Reagents and antibodies
All reagents were from Sigma (St Louis, MO), unless otherwise indicated. The rabbit
polyclonal CTR1 antibody (Nose et al., 2006) was kindly provided by Dennis Thiele
(Duke University, Durham, NC). The rabbit polyclonal antibody against ATP7A was
raised against the C-terminal portion of the protein and was a generous gift from
Elizabeth Eipper (Steveson et al., 2003). Additional affinity purified anti-ATP7A
antibodies were raised in rabbits against the synthetic peptide NH2-
CDKHSLLVGDFREDDDTTL-COOH (Bethyl Laboratories, Mongomery, TX). Anti-
tubulin antibody, and secondary HRP-conjugated antibodies were purchased from
Roche Molecular Biochemicals. Antibodies against COXI, and fluorescent Alexa
Fluor 488- and Alexa Fluor 594-conjugated antibodies were from Invitrogen
(Carlsbad, CA). Antibodies against GM130 and syntaxin 6 were purchased from BD
Transduction Laboratories (San Jose, CA). Antibodies against CD68 and HIF1αwere
purchased from Serotec (Raleigh, NC) and Novus Biologicals (Littleton, CO),
respectively. Antibodies against Cu/Zn-SOD, CCS and ceruloplasmin antibodies were
purchased from Stressgen (Ann Arbor, MI), Santa Cruz Biotechnology (Santa Cruz,
CA), and Abcam (Cambridge, MA), respectively.
Cell culture
All cell lines were obtained from the American Type Culture Collection and were
maintained in Dulbecco’s modified Eagle’s medium (Invitrogen) containing 10% fetal
bovine serum and 100 i.u./ml penicillin and streptomycin (Invitrogen) in 5% CO2 at
37°C. Primary macrophages were isolated by peritoneal lavage. C57BL/6J mice were
injected with 2 ml of thioglycolate medium into the peritoneum to elicit macrophage
infiltration. After 72 hours, macrophages were isolated by peritoneal lavage using
ice-cold PBS. Cells were seeded in six-well plates for each experiment as described.
Hypoxic atmospheres were generated by displacement with N2 and CO2 gas using a
trigas hypoxic incubator. RNAi-mediated silencing of ATP7A in RAW264.7 cells
was performed by stable transfection of a pRS vector expressing a 29 nucleotide
short hairpin (sh) RNA against ATP7A (Origene, Rockville, MD) followed by selection
in 25 μg/ml puromycin. Control cells were transfected with the same vector
expressing shRNA against GFP. Lipofectamine 2000 (Invitrogen) was used in all
transfections.
Copper uptake
Radioactive copper (64Cu) was purchased from the Mallinckrodt Institute of Radiology,
Washington University (Saint Louis, MO). Cells were pre-cultured in triplicate for
72 hours in 6-well plates under either normoxic (21% O2) or hypoxic (4% O2)
conditions, and then exposed to 1 μM 64Cu for 5 minutes, washed extensively in ice-
cold PBS and radioactivity measured using a gamma counter. Counts were normalized
against total protein.
Immunocytochemistry and PC-3 tumor xenografts
Immunofluorescence microscopy and western blot analysis were performed as
described previously (Mao et al., 2007). PC-3 prostate carcinoma cells (5106) were
injected subcutaneously into one flank of anesthetized 4-week-old ICRSC-M SCID
mice obtained from Taconic (Germantown, NY). Mice were maintained in an approved
pathogen-free institutional housing and studies were conducted as outlined in the
NIH Guidelines for the Care and Use of Laboratory Animals and the Policy and
Procedures for Animal Research of the Harry S. Truman Veterans Memorial Hospital.
After a period of 4 weeks solid tumors of appropriately 1 cm diameter were excised
from anesthetized mice and flash frozen in isopentane. Frozen tumors were
cryosectioned, fixed in acetone for 10 minutes, washed in phosphate-buffered saline
(PBS) and blocked overnight in 1% casein in PBS. Immunostaining was performed
using antibodies against ATP7A, CD68 or HIF1α, followed by staining with Alexa
Fluor 488 anti-rabbit and Alexa Fluor 594 anti-mouse antibodies, as indicated in the
figure legends. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI).
Enzyme assays
CCO activity assays were performed using mitochondrial preparations from
RAW264.7 cells obtained using the Cell Mitochondria Isolation Kit from Sigma.
CCO activity was measured using a CCO assay kit (Sigma) according to the
manufacturer’s instructions and activity was normalized against mitochondrial protein
content.
Superoxide dismutase assays were performed as described previously (Flohe and
Otting, 1984). Briefly, RAW264.7 cell lysates were fractionated using nondenaturing
12% polyacrylamide gel electrophoresis and superoxide dismutase activity was
detected by incubation of gels in nitro blue tetrazolium at room temperature.
Ceruloplasmin activity in concentrated conditioned media was determined by its p-
phenylenediamine oxidase activity as previously described (Sunderman and Nomoto,
1970). RAW264.7 cells were grown in 6-well plates and the conditioned medium
was collected and concentrated using Amicon Ultra-4 filter tubes (Millipore). A low
level of endogenous ceruloplasmin activity in concentrated medium alone was
subtracted from that of conditioned medium for each experiment. Ceruloplasmin
activity was normalized against total protein content in the cell pellets. Ceruloplasmin
protein levels were detected in concentrated medium using immunoblot analysis.
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